Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Acquisition

2 Feb 2015 07:00

RNS Number : 6949D
Fenner PLC
02 February 2015
 

02 February 2015

Fenner PLC ("Fenner")

Acquisition of Charter Medical Limited ("Charter")

Fenner is pleased to announce that its wholly owned subsidiary Fenner Drives, Inc. has acquired 100% of the share capital of Charter from its parent company Lydall, Inc. a publicly traded company (NYSE: LDL) headquartered in Connecticut. Charter will be integrated into Solesis Medical Technologies ("Solesis"), part of Fenner's AEP division.

The consideration of US$29.9m was satisfied in cash at completion and the transaction is expected to be earnings enhancing immediately upon acquisition.

Charter manufactures specialty single-use assemblies and Class I and Class II medical devices for the collection, processing, storage and filtration of biological and bioprocessing fluids. Charter also produces bio-containers and fluid management sets that serve a range of life science applications including biopharmaceutical manufacturing, cell therapy and cryogenic storage. Charter is a single site company based in Winston-Salem, North Carolina.

As at 31 December 2014, unaudited gross assets acquired were US$6.9m with underlying EBITDA (1) of US$3.3m for the 12 months to 31 December 2014 on sales of US$19.6m. 

The entire workforce of Charter have become employees of Fenner upon completion and will continue to be led by General Manager, Mr. Gael Peron.

Nick Hobson, CEO of Fenner PLC, commented:

"In common with all businesses in our AEP division, Charter applies its polymer technology to solving problems in performance-critical applications. Charter has a strong, established business in blood transfusion and filtration markets and has exciting opportunities in the bio-processing and regenerative medicine markets, in which Fenner is already active and which are experiencing rapid growth. 

The acquisition of Charter, which will provide an attractive addition to the capabilities and offerings of Solesis, continues Fenner's strategy to develop our medical business both organically and by acquisition."

For further information please contact:

 

Fenner PLC 01482 626501

Nick Hobson, Chief Executive

John Pratt, Finance Director

 

Weber Shandwick Financial 020 7067 0700

Nick Oborne / Tom Jenkins

 

 

(1) Adjusted for historic non-recurring items

 

Notes to editors:

 

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas and medical which account for some 40 per cent of divisional revenue, together with construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical and Xeridiem.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUARWRVBAURAR
Date   Source Headline
8th Oct 20094:24 pmRNSHolding(s) in Company
5th Oct 20094:51 pmRNSNotice of Results
7th Sep 20097:00 amRNSPre-Close Trading Update
2nd Sep 200910:34 amRNSBlocklisting Interim Review
1st Sep 200910:38 amRNSDirector/PDMR Shareholding
10th Aug 20094:16 pmRNSHolding(s) in Company
17th Jul 20092:34 pmRNSHolding(s) in Company
17th Jul 20097:00 amRNSInterim Management Statement
22nd Jun 20099:16 amRNSHolding(s) in Company
19th Jun 20093:54 pmRNSHolding(s) in Company
9th Jun 20099:48 amRNSHolding(s) in Company
3rd Jun 20099:17 amRNSHolding(s) in Company
29th Apr 20097:00 amRNSHalf Year Results
14th Apr 200910:10 amRNSNotice of Results
1st Apr 20094:24 pmRNSHolding(s) in Company
26th Mar 20099:16 amRNSHolding(s) in Company
20th Mar 20099:05 amRNSHolding(s) in Company
12th Mar 20097:00 amRNSPre-Close Trading Update
5th Mar 20099:54 amRNSBlocklisting Interim Review
5th Feb 200912:53 pmRNSHolding(s) in Company
5th Feb 20099:36 amRNSHolding(s) in Company
28th Jan 20099:29 amRNSHolding(s) in Company
20th Jan 20099:59 amRNSHolding(s) in Company
14th Jan 200910:30 amRNSAGM and IMS
8th Jan 20092:59 pmRNSAnnual Information Update
2nd Jan 20099:56 amRNSHolding(s) in Company
24th Dec 200812:40 pmRNSSecond Price Monitoring Extn
24th Dec 200812:35 pmRNSPrice Monitoring Extension
23rd Dec 20089:21 amRNSHolding(s) in Company
22nd Dec 20089:46 amRNSHolding(s) in Company
12th Dec 20082:15 pmRNSHolding(s) in Company
11th Dec 20084:01 pmRNSNotice of AGM
8th Dec 20083:23 pmRNSDirector/PDMR Shareholding
3rd Dec 20089:21 amRNSDirector/PDMR Shareholding
24th Nov 200811:53 amRNSDirector/PDMR Shareholding
24th Nov 200811:47 amRNSDirector/PDMR Shareholding
21st Nov 200810:33 amRNSDirector/PDMR Shareholding
20th Nov 20082:59 pmRNSHolding(s) in Company
19th Nov 200810:21 amRNSDirector/PDMR Shareholding
14th Nov 20084:29 pmRNSDirector/PDMR Shareholding
14th Nov 200812:22 pmRNSDirector/PDMR Shareholding
14th Nov 200812:16 pmRNSDirector/PDMR Shareholding
14th Nov 200812:09 pmRNSDirector/PDMR Shareholding
14th Nov 200812:01 pmRNSDirector/PDMR Shareholding
13th Nov 20084:48 pmRNSDirector/PDMR Shareholding
13th Nov 200812:53 pmRNSDirector/PDMR Shareholding
13th Nov 200812:43 pmRNSDirector/PDMR Shareholding
13th Nov 200812:38 pmRNSDirector/PDMR Shareholding
12th Nov 20087:00 amRNSFinal Results
21st Oct 200812:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.